AI healthcare market projected to reach $196.8 billion by 2034

The global artificial intelligence healthcare revenue cycle management (RCM) market is projected to reach $196.8 billion by 2034. As AI adoption moves beyond the pilot stage, between 20% and 40% of surveyed organizations report enterprise-wide use of AI-enabled tools. A primary driver for this growth is denial management, as many providers report denial rates of at least 10% due to registration errors and inaccurate claim information.

In the clinical sector, competition between frontier AI models is accelerating innovation. The release of Moonshot AI’s Kimi K3 has narrowed the performance gap with US models, potentially benefiting healthcare through increased customizability and cost-effectiveness. Additionally, academic medical centers in the United States are shifting from purchasing ready-made products to partnering directly with technology firms to co-develop clinical AI tools, exchanging deidentified patient data and clinician expertise for engineering and cloud computing resources.